Over 8,000 patients treated Research driven products Microdosing Tirzepatide Starting at $585.00 Tirzepatide Starting at $399.00 Semaglutide Starting at $299.00 Nutrient Injections Starting at $25.00 PT-141 Starting at $199.00 Methylene Blue Starting at $99.00 Metformin Starting at $49.00 Sermorelin Starting at $249.00 IV Therapy Starting at $350.00 NAD+ Wafers Starting at $100.00 TRT with Enclomiphene Starting at $289.00 FBHRT Starting at $289.00 GLP-1 + GIP Starting at $399.00 GLP-1 Starting at $299.00 NAD+ Injections Starting at $249.00 Contact us today Personalized plans by clinical experts In-depth diagnostic testing before treatment begins Ongoing support for lasting results We start with advanced testing, turn your data into a personalized plan, and track progress to keep you improving
One major study is looking at heart health, specifically whether CagriSema can reduce the risk of heart attacks and strokes in people with existing heart disease
Clinical studies have shown that Wegovy, a different dosage of semaglutide, the drug found in Ozempic and Rybelsus, is effective in lowering the risk of cardiovascular events in those who are overweight or obese
Who wins the battle against obesity
Supportive Weight Management : This program equips patients with effective strategies and tools to help maintain their weight with the support of our expert doctors and specialists
Complex oscillatory waves emerging from cortical organoids model early human brain network development